Latest news
-
TIBIO – Azienda ticinese selezionata tra gli attori chiave nel mercato mondiale dei prodotti chimici basati sulle biotecnologie
A Consulting Company for Scientific... -
Helsinn announces publication of new data evaluating impact of NEPA (netupitant/palonosetron) on hospital costs
LUGANO, Switzerland - February 3, 2023 - Helsinn Group... -
Helsinn and Immedica enter exclusive partnership for commercialisation of cancer supportive care products in core European markets
LUGANO, Switzerland and STOCKHOLM, Sweden – January 24, 2023...
Linkedin